Cryptocurrencies
From Seed to Sale: What VC’s Want in Biotech Startups
Dr. Andrew Snyder (Monash University) joins the show to discuss the current biotech landscape: rising M&A and IPO activity, where clinical-stage assets are attracting buyers, and which therapeutic areas are gaining momentum (oncology, rare disease, Read more…